Literature DB >> 19154345

cGMP-dependent protein kinase II and aldosterone secretion.

Beate Spiessberger1, Dominik Bernhard, Stefan Herrmann, Susanne Feil, Claudia Werner, Peter B Luppa, Franz Hofmann.   

Abstract

ACTH-stimulated aldosterone secretion can be inhibited by atrio-natriuretic peptide/cGMP. The mechanism behind this modulation has been reported to involve cGMP-dependent activation of phosphodiesterase 2 (PDE2) and hydrolysis of cAMP. Recently it was reported that activation of cGMP-dependent protein kinase II (cGKII) stimulated aldosterone secretion in rat zona glomerulosa cells. The zona glomerulosa of the murine adrenal cortex expresses cGKII and PDE2. We used mice with a homozygous inactivation of the cGKII gene to investigate in vivo the potential role of this kinase in aldosterone secretion. Basal plasma renin and aldosterone levels were similar in wild-type and cGKII(-/-) mice. In vivo injection of atrio-natriuretic peptide decreased ACTH-stimulated aldosterone secretion in wild-type mice, but had no effect in cGKII-deficient mice. These results support the view that cGKII modulates aldosterone secretion in the murine adrenal cortex.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19154345     DOI: 10.1111/j.1742-4658.2008.06839.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  11 in total

Review 1.  The roles of cyclic nucleotide phosphodiesterases (PDEs) in steroidogenesis.

Authors:  Li-Chun Lisa Tsai; Joseph A Beavo
Journal:  Curr Opin Pharmacol       Date:  2011-09-29       Impact factor: 5.547

2.  Function of cGMP-dependent protein kinase II in volume load-induced diuresis.

Authors:  Andrea Schramm; Elisabeth Schinner; Johannes P Huettner; Frieder Kees; Philipp Tauber; Franz Hofmann; Jens Schlossmann
Journal:  Pflugers Arch       Date:  2014-01-18       Impact factor: 3.657

Review 3.  Clinical and molecular genetics of the phosphodiesterases (PDEs).

Authors:  Monalisa F Azevedo; Fabio R Faucz; Eirini Bimpaki; Anelia Horvath; Isaac Levy; Rodrigo B de Alexandre; Faiyaz Ahmad; Vincent Manganiello; Constantine A Stratakis
Journal:  Endocr Rev       Date:  2013-12-05       Impact factor: 19.871

4.  MANP Activation Of The cGMP Inhibits Aldosterone Via PDE2 And CYP11B2 In H295R Cells And In Mice.

Authors:  Yang Chen; Seethalakshmi R Iyer; Viacheslav O Nikolaev; Fabio Naro; Manuela Pellegrini; Silvia Cardarelli; Xiao Ma; Hon-Chi Lee; John C Burnett
Journal:  Hypertension       Date:  2022-06-08       Impact factor: 9.897

Review 5.  The Biology of Normal Zona Glomerulosa and Aldosterone-Producing Adenoma: Pathological Implications.

Authors:  Teresa M Seccia; Brasilina Caroccia; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez; Gian Paolo Rossi
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

Review 6.  Phosphodiesterase type 5 and cancers: progress and challenges.

Authors:  Ines Barone; Cinzia Giordano; Daniela Bonofiglio; Sebastiano Andò; Stefania Catalano
Journal:  Oncotarget       Date:  2017-10-12

7.  Phosphodiesterase 2A and 3B variants are associated with primary aldosteronism.

Authors:  Marcela Rassi-Cruz; Andrea G Maria; Fabio R Faucz; Edra London; Leticia A P Vilela; Lucas S Santana; Anna Flavia F Benedetti; Tatiana S Goldbaum; Fabio Y Tanno; Vitor Srougi; Jose L Chambo; Maria Adelaide A Pereira; Aline C B S Cavalcante; Francisco C Carnevale; Bruna Pilan; Luiz A Bortolotto; Luciano F Drager; Antonio M Lerario; Ana Claudia Latronico; Maria Candida B V Fragoso; Berenice B Mendonca; Maria Claudia N Zerbini; Constantine A Stratakis; Madson Q Almeida
Journal:  Endocr Relat Cancer       Date:  2021-01       Impact factor: 5.678

Review 8.  Alterations of Phosphodiesterases in Adrenocortical Tumors.

Authors:  Fady Hannah-Shmouni; Fabio R Faucz; Constantine A Stratakis
Journal:  Front Endocrinol (Lausanne)       Date:  2016-08-30       Impact factor: 5.555

9.  Transcription controls growth, cell kinetics and cholesterol supply to sustain ACTH responses.

Authors:  Robert I Menzies; Xin Zhao; Linda J Mullins; John J Mullins; Carolynn Cairns; Nicola Wrobel; Donald R Dunbar; Matthew A Bailey; Christopher J Kenyon
Journal:  Endocr Connect       Date:  2017-07-18       Impact factor: 3.335

10.  Phosphodiesterase 2 inhibition preferentially promotes NO/guanylyl cyclase/cGMP signaling to reverse the development of heart failure.

Authors:  Reshma S Baliga; Michael E J Preedy; Matthew S Dukinfield; Sandy M Chu; Aisah A Aubdool; Kristen J Bubb; Amie J Moyes; Michael A Tones; Adrian J Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.